Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Authors:
Padmanee Sharma, Arlene Siefker-Radtke, Filippo de Braud, Umberto Basso, Emiliano Calvo, Petri Bono, Michael A Morse, Paolo A Ascierto, Jose Lopez-Martin, Peter Brossart, Kristoffer Rohrberg, Begoña Mellado, Bruce S Fischer, Stephanie Meadows-Shropshire, Abdel Saci, Margaret K Callahan, Jonathan Rosenberg
Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy.
Frontiers in oncology
Authors:
Katjana S Schwab, Glen Kristiansen, Alexander Isaak, Stefanie E A Held, Annekristin Heine, Peter Brossart
Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors.
Clinical nuclear medicine
Authors:
Anna Yordanova, Harriet Ahrens, Georg Feldmann, Peter Brossart, Florian C Gaertner, Christian Fottner, Matthias M Weber, Hojjat Ahmadzadehfar, Mathias Schreckenberger, Matthias Miederer, Markus Essler
The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma.
Bone marrow transplantation
Authors:
Tobias A W Holderried, Alessia Fraccaroli, Martin Schumacher, Annkristin Heine, Peter Brossart, Matthias Stelljes, Sebastian Klobuch, Nicolaus Kröger, Petya Apostolova, Jürgen Finke, Robert Zeiser, Thomas Heinicke, Martin Bornhäuser, Michael von Bergwelt-Baildon, Johanna Tischer, Dominik Wolf